Ga verder naar de inhoud
Menu
Home Portfolio

Portfolio

Over the years, CD3 has collaborated with academic research groups and companies in more than 30 projects in order to develop potential new medicines for various disorders. Browse through our portfolio to get an overview of both our partnered and ongoing projects. To view our ongoing projects which are available to pharmaceutical and biotech companies for further development, please check out our pipeline.

Get in touch
Discover our project pipeline
Filters

Filter through investments

Project status

Therapeutic area

A total of 31 items found. Showing 12 items on page 1 of 3
Rsv klein
Infectious diseases
Image

RSV antivirals

Partnered project
Disease: RSV
Pain klein
CNS
Image

TRPM3 antagonists

Partnered project
Disease: Pain
Yap TAZ TEAD inhibitors klein
Cancer
Image

Yap/TAZ-TEAD inhibitors

Partnered project
Disease: Mesothelioma, lung cancer ao
Sars klein
Infectious diseases
Image

SARS-Cov-2 treatment

Partnered project
Disease: COVID-19
Cancer genomic instability klein
Cancer
Image

Cancer therapy targeting genomic instability

Partnered project
Disease: Hematological / solid cancers
Heart failure 2 klein
Cardiovascular
Image

Treatment for heart failure

Partnered project
Disease: Heart failure
Multiple sclerosis
CNS
Image

Treatment for Multiple Sclerosis

Partnered project
Disease: Multiple Sclerosis
Influenza klein
Infectious diseases
Image

Influenza virus inhibitors

Partnered project
Disease: Influenza
Malt1 galapagos klein
Inflammation - Immunity
Image

MALT1 inhibitors

Partnered project
Disease: Auto-immune diseases
Pain klein
CNS
Image

New treatment for pain

Partnered project
Disease: Pain
Hts preview robot
Image

State-of-the-art high throughput screening

Partnered project
Hrv inhibitors klein
Infectious diseases
Image

HRV inhibitors

Partnered project
Disease: Human rhinovirus

Want to know more about one of these projects?

Send us a message. We are looking forward to collaborating with you!